In your fight against HER2-positive metastatic breast cancer, nothing is more important than support and information as you weigh your treatment options. The doctors and researchers involved in this research study understand the critical nature of your decisions at this time.
The HER2+ Research Study is examining the safety and effectiveness of an investigational treatment for HER2-positive metastatic breast cancer. We ask that you read the following information and think about whether you may be interested in study participation.